HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of AGTR1 gene A1166C polymorphism with the risk of heart failure: a meta-analysis.

Abstract
The aim of this study was to investigate the correlation between the A1166C polymorphism in the angiotensin II type 1 receptor (AT1R) gene and heart failure (HF) risk using meta‑analysis. The PubMed database was searched, and data were extracted independently by two reviewers. Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the associations. Statistical analysis was performed using the STATA 12.0 software. The results of the meta‑analysis showed no significant association between the AT1R A1166C polymorphism and HF risk (AA vs CC: OR = 0.72, 95%CI = 0.31-1.68; AA vs AC: OR = 0.78, 95%CI = 0.52-1.18; dominant model: OR = 1.37, 95%CI = 0.92-2.04; recessive model: OR = 0.73, 95%CI = 0.30-1.75). In the subgroup analysis by ethnicity, the results also showed no significant association between A1166C polymorphism and susceptibility to HF in both Caucasian and Asian populations. In conclusion, this meta-analysis suggests that the A1166C polymorphism in AT1R may not be associated with susceptibility to HF. Further large and well-designed studies are needed to confirm these conclusions.
AuthorsJ A Zhang, J R Li, Y J Qiao
JournalGenetics and molecular research : GMR (Genet Mol Res) Vol. 14 Issue 3 Pg. 9163-70 (Aug 07 2015) ISSN: 1676-5680 [Electronic] Brazil
PMID26345849 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • AGTR1 protein, human
  • Codon
  • Receptor, Angiotensin, Type 1
Topics
  • Alleles
  • Amino Acid Substitution
  • Case-Control Studies
  • Codon
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Heart Failure (genetics)
  • Humans
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Publication Bias
  • Receptor, Angiotensin, Type 1 (genetics)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: